Travel and Tourism in Spain: JSBMarketResearch

Summary

 The Spanish economy contracted during 2009-2014, following the economic crisis and high unemployment rates. Both domestic and outbound tourism recorded a decline, whereas inbound tourism registered growth There has been a strong rise in tourists from the UK in recent years due to the appreciation of the pound. However, trips from Russia declined due to the imposed economic sanctions.

 Key Findings

 - Due to economic slowdown, the countrys tourism is struggling as it posted a decline in the domestic and outbound tourist numbers. The total number of domestic trips fell from 155 million in 2009 to 139.6 million in 2014 whereas the outbound trips declined to11.8 million in 2014. Lower disposable incomes of the Spanish people was one of the major reason for this decline. Due to the ongoing crisis, more demand was generated by lower ticket prices of Low Cost Carriers (LCCs) with their overall market share increasing from 44.2% in 2009 to 52.2% in 2014. However, international arrivals increased from 52.2 million in 2009 to 65 million in 2014. Europe has been the key source market for the Spanish tourism industry. About 14.6 million Britons visited the country in 2014, making it the top market for the country, followed by 10.6 million tourists from Germany

 - The UK continues to be the largest market for LCCs flying to Spain. In the first two months of 2015, a rise of 9.3% was recorded in the number of visitors from the UK to Spain, who opted for low cost flights. During the same period, almost 3.3 million tourists traveled to and from Spain on low cost flights which shows an increase of almost 14.4% compared to the previous year. Moreover, in February 2015, airlines including Ryanair, EasyJet and Vueling together were accountable for 30% of all the international travelers

 - After years of decline, following the increasing number of foreign arrivals, Spain is again attracting back hotel investors. As per the Investment Real Estate Associates (IREA), Madrid based real estate consultancy, an investment of almost EUR791 million (US$1 billion) was put into the Spanish hotel sector. As per IREA report, Barcelona and Madrid were among the top investment destinations

 Synopsis

 Canadeans report - Travel and Tourism in Spain to 2019 - provides detailed information on the countys tourism sector, analyzing market data and providing insights. This report provides a better understanding of tourism flows, expenditure, and the airline, hotel, car rental, and travel intermediaries industries.

 For more information on this report visit –

 http://www.jsbmarketresearch.com/travel-tourism/r-travel-and-tourism-in-spain-to-2019-210086
 
 What else does this report offer?

 - Historic and forecast tourist volumes covering the entire Spanish Travel and Tourism sector

 - Detailed analysis of tourist spending patterns for various categories, such as accommodation, sightseeing entertainment, foodservice, transportation, retail, travel intermediaries, and others

 - Analysis of trips by purpose and mode of transport, and expenditure across various categories including domestic, inbound, and outbound tourism,

 - Analysis of the airline, hotel, car rental, and travel intermediaries industries by customer type - leisure and business travelers

 ReasonsToBuy

 - Make strategic business decisions using historic and forecast market data related to Spains Travel and Tourism sector

 - Understand the demand-side dynamics within the industry to identify key market trends and growth opportunities

 - Direct promotional efforts on the most promising markets by identifying the key source and destination countries

 For More Related Market Research Reports click here:
  Travel and Tourism in Canada to 2019
 
 Travel and Tourism in Brazil to 2019
 
 Travel and Tourism Market Research

European Internal Neurostimulation Market

The European internal neurostimulation devices market is mainly driven by rapidly aging population and associated diseases like Alzheimer’s, epilepsy, spinal cord injury, and Parkinson’s disease. The European internal neurostimulation market was $947.8 million in 2013, and is expected to reach $1715.8 million by 2018 at a CAGR of 13.0%. The internal neuromodulation market was the largest segment constituting 87% of the overall neurostimulation market.

The report ‘The European  Neurostimulation Devices Market forecast, 2012-2018’ analyzes internal neurostimulation market segmented by modalities including spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES), and by applications such as chronic pain, failed back surgery syndrome, refractory angina pectoris, peripheral neuropathy, Alzheimer’s, Dystonia, Tourette’s Syndrome, Parkinson’s, epilepsy, fecal incontinence, and urine incontinence and gastroparesis.

These segments experienced a positive growth until 2012, with an increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $2.3 and $0.6 billion, the spinal cord stimulation (SCS) and deep brain stimulation (DBS) segments contributed 51% and 14%, in terms of value, towards the total internal neurostimulation device market. Both the markets have been witnessing high growth because of the increase in patient pool and procedure numbers of the various modalities.

 Procedure volume growth is significantly higher in BIC (Brazil, India, China) and Mexico because of fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people.

The prevalence of Alzheimer’s in North America and Europe is around 5.4-6.4% in adult population whereas in Asia, it is around 4%. The incidences of Alzheimer’s were 411,000 in 2000. This number increased to 454,000 in 2010, and is expected to reach 615,000 by 2030 and 959,000 by 2050. Such high incidence rates in neurological disorders will positively affect the market for neuromodulation.

The report also provides an extensive competitive landscaping of companies operating in the European internal neurostimulation market. Major players dominating the European internal neurostimulation market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), and Neuronetics, Inc. (U.S.) Emerging players in this market include Biocontrol Medical, ANM Neuromodulation GmbH, and Magstim Company Limited.

Segment and country-specific company shares, news & deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.

 Customization Options

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

 Product Analysis

 Usage pattern (in-depth trend analysis) of products (segment wise)

 Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level

 End-user adoption rate analysis of the products (segment wise and country wise)

 Comprehensive coverage of product approvals, pipeline products, and product recalls

 Epidemiology Data

 Country-specific prevalence of Alzheimer’s ,Parkinson’s, epilepsy and stroke

 Country-specific incidence of Alzheimer’s, Parkinson’s, epilepsy, stroke

 Country-specific mortality rate of stroke and epilepsy

 Country-specific patient pool of Alzheimer’s, Parkinson’s, epilepsy and stroke

 Disease progression (pattern analysis)

For more information on this report visit –
 

http://www.jsbmarketresearch.com/healthcare-medical/r-european-internal-neurostimulation-market-184898

 Procedure Volume Data

Country-wise number of surgeries for epilepsy, heart failure, Alzheimer’s, and Parkinson’s

 Surgeons/Physicians Perception analysis

 Fast turn-around analysis of surgeons’ response to market events and trends

 Pattern analysis of usage of spinal cord stimulation (SCS) and deep brain stimulation (DBS) by physicians

 Surgeons’ opinion about products from different companies

 Surgeons’ qualitative inputs on epidemiology data

 Brand/Product Perception Matrix

 Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs

 Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)

Pricing Trends

Cost analysis of the European internal neurostimulation devices

 The European internal neurostimulation procedural investment

 Competitive Intelligence

 The company share analysis for the top players of this market in Europe

 The crucial developments and strategies of the companies inculcated in their portfolio of the European internal neurostimulation market

For More Related Market Research Reports click here:

• Patient Monitoring and Diagnostic Systems Companies in China

• OTC Drugs Companies in China

• Healthcare and Medical Market Research